T-2 toxin induced skin inflammation and cutaneous injury in mice

Toxicology

Volumn 302, Issue 2-3, 2012, Pages 255-265

  Agrawal, Mona ^a   Yadav, Preeti ^a   Lomash, Vinay ^a   Bhaskar, A S B ^a   Lakshmana Rao, P V ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Cytokines; Matrix metalloproteinases; Skin inflammation; Skin toxicity; T 2 toxin

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; T 2 TOXIN; TUMOR NECROSIS FACTOR ALPHA; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL VACUOLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIDERMIS CELL; EXPERIMENTAL DERMATITIS; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOBLOTTING; INFLAMMATORY CELL; LIPID PEROXIDATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN DEFECT; SKIN INJURY; SKIN OXIDATIVE STRESS; T 2 TOXIN INDUCED SKIN INFLAMMATION; TOXICITY; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; DERMATITIS; DOSE RESPONSE; DRUG EFFECT; FUSARIUM; GENETICS; KERATINOCYTE; LD 50; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SKIN;

ANIMALIA; MUS;

ANIMALS; APOPTOSIS; DERMATITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FUSARIUM; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; KERATINOCYTES; LETHAL DOSE 50; LIPID PEROXIDATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIDASE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SKIN; T-2 TOXIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84897122215     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.08.007     Document Type: Article

References (53)

1. Agrawal, M., Pardasani, D., Lakshmana Rao, P.V., 2012. Evaluation of protective efficacy of CC2 formulation against topical lethal dose of T-2 toxin in mice. Food Chem. Toxicol. 50, 1098-1108.
2. Albarenque, S.M., Doi, K., 2005. T-2 toxin-induced apoptosis in rat keratinocyte primary cultures. Exp. Mol. Pathol. 78, 144-149.
3. Albarenque, S.M., Suzuki, K., Nakayama, H., Doi, K., 2001a. Kinetics of cytokines mRNAs expression in the dorsal skin of WBN/ILA-Ht rats following topical application of T-2 toxin. Exp. Toxicol. Pathol. 53, 271-274.
4. Albarenque, S.M., Suzuki, K., Shinozuka, J., Nakayama, H., Doi, K., 2001b. Kinetics of apoptosis-related genes mRNA expression in the dorsal skin of hypotrichotic WBN/ILA-ht rats after topical application of T-2 toxin. Exp. Toxicol. Pathol. 52, 553-556.
5. Albarenque, S.M., Shinozuka, J., Iwamoto, S., Nakayama, H., Doi, K., 1999. T-2 toxininduced acute skin lesions in Wistar-derived hypotrichotic WBN/ILA-Ht rats. Histol. Histopathol. 14, 337-342.
6. Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., Opdenakker, G., Sorokin, L.M., 2006. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 203, 1007-1019.
7. Bondy, G.S., Pestka, J.J., 2000. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 3, 109-143.
8. Bouaziz, C., Sharaf El Dein, O., El Golli, E., Abid-Essefi, S., Brenner, C., Lemaire, C., Bacha, H., 2008. Different apoptotic pathways induced by zearalenone. T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology 254, 19-28.
9. Bradley, P.P., Priebat, D.A., Christensen, R.D., Rothstein, G., 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206-209.
10. Briganti, S., Picardo, M., 2003. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J. Eur. Acad. Dermatol. Venereol. 17, 663-669.
11. Bunner, D.L., Morris, E.R., 1988. Alteration of multiple cell membrane functions in L-6 myoblasts by T-2 toxin: an important mechanism of action. Toxicol. Appl. Pharmacol. 92, 113-121.
12. Bunner, D.L., Upshall, D.G., Bhatti, A.R.,1985. Toxicology data on T-2 toxin. In: Report of Focus Officers Meeting on Mycotoxin Toxicity, 23-24 September. Defense Research Establishment at Suffield, Suffield, Alberta, Canada.
13. Chaudhari, M., Jayaraj, R., Bhaskar, A.S., Lakshmana Rao, P.V., 2009. Oxidative stress induction by T-2 toxin causes DNA damage and triggers apoptosis via caspase pathway in human cervical cancer cells. Toxicology 262, 153-161.
14. Chaudhary, M., Lakshmana Rao, P.V., 2010. Brain oxidative stress after dermal and subcutaneous exposure of T-2 toxin in mice. Food Chem. Toxicol. 48, 3436-3442.
15. Creasia, D.A., Thurman, J.D., Jones, L.J., 3rd, Nealley, M.L., York, C.G., Wannemacher Jr., R.W., Bunner, D.L., 1987. Acute inhalation toxicity of T-2 mycotoxin in mice. Fundam. Appl. Toxicol. 8, 230-235.
16. Creasia, D.A., Thurman, J.D., Wannemacher Jr., R.W., Bunner, D.L., 1990. Acute inhalation toxicity of T-2 mycotoxin in the rat and guinea pig. Fundam. Appl. Toxicol. 14, 54-59.
17. De Vry, C.G., Valdez, M., Lazarov, M., Muhr, E., Buelow, R., Fong, T., Iyer, S., 2005. Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model. J. Invest. Dermatol. 125, 473-481.
18. Elkington, P.T., O'Kane, C.M., Friedland, J.S., 2005. The paradox of matrix metalloproteinases in infectious disease. Clin. Exp. Immunol. 142, 12-20.
19. Gad, S.C., Weil, S., 1989. Statistics for toxicologist. In: Hates, A.W. (Ed.), Principles and Methodology of Toxicology, second ed. Raven Press, New York, pp. 463-467.
20. Haschek, W.M., Beasley, V.R., 2009. Trichothecene Mycotoxins. In: Gupta, R.C. (Ed.), Handbook of Toxicology of Chemical Warfare Agents. Elsevier Inc., Academic press, USA, pp. 353-369.
21. Kalantari, H., Moosavi, M., 2010. Review on T-2 Toxin. Jundishapur J. Nat. Pharm. Prod. 5, 26-38.
22. Kemppainen, B.W., Riley, R.T., Joyave, J.L., Hoerr, F.J., 1987. In vitro percutaneous penetration and metabolism of [3H]T-2 toxin: comparison of human, rabbit, guinea pig rat. Toxicon 25, 185-194.
23. Kemppainen, B.W., Riley, R.T., Pace, J.G., Hoerr, F.J., 1986. Effects of skin storage conditions and concentration of applied dose on [3H]T-2 toxin penetration through excised human and monkey skin. Food Chem. Toxicol. 24, 221-227.
24. Li, M., Cuff, C.F., Pestka, J.J., 2006. T-2 toxin impairment of enteric reovirus clearance in the mouse associated with suppressed immunoglobulin and IFN-gamma responses. Toxicol. Appl. Pharmacol. 214, 318-325.
25. Lilleholt, L.L., Johansen, C., Arthur, J.S., 2011. Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-Otetradecanoylphorbol 13-acetate. Acta Derm. Venereol. 91, 271-278.
26. Lowes, M.A., Bowcock, A.M., Krueger, J.G., 2007. Pathogenesis and therapy of psoriasis. Nature 445, 866-873.
27. Medeiros, R., Figueiredo, C.P., Passos, G.F., Calixto, J.B., 2009. Reduced skin inflammatory response in mice lacking inducible nitric oxide synthase. Biochem. Pharmacol. 78, 390-395.
28. Medicherla, S., Ma, J.Y., Reddy, M., 2010. Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig. J. Inflamm. Res. 3, 9-16.
29. Meindl, S., Schmidt, U., Vaculik, C., Elbe-Burger, A., 2006. Characterization, isolation, and differentiation of murine skin cells expressing hematopoietic stem cell markers. J. Leukoc. Biol. 80, 816-826.
30. Mirocha, C.J., Pawlosky, R.A., Chatterjee, K., Watson, S., Hayes, W., 1983. Analysis for Fusarium toxins in various samples implicated in biological warfare in Southeast Asia. J. Assoc. Off. Anal. Chem. 66, 1485-1499.
31. Nathan, C., Xie, Q.W., 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915-918.
32. Nguansangiam, S., Angsubhakorn, S., Bhamarapravati, S., Suksamrarn, A., 2003. Effects of elephant garlic volatile oil (Allium ampeloprasum) and T-2 toxin on murine skin. Southeast Asian J. Trop. Med. Public Health 34, 899-905.
33. Ohkawa, H., Ohishi, N., Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
34. Ono, K., Han, J., 2000. The p38 signal transduction pathway: activation and function. Cell. Signal. 12, 1-13.
35. Pang, V.F., Swanson, S.P., Beasley, V.R., Buck, W.B., Haschek, W.M., 1987. The toxicity of T-2 toxin in swine following topical application. I. Clinical signs, pathology, and residue concentrations. Fundam. Appl. Toxicol. 9, 41-49.
36. Pestka, J.J., Zhou, H.R., Moon, Y., Chung, Y.J., 2004. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol. Lett. 153, 61-73.
37. Ravindran, J., Agrawal, M., Gupta, N., Lakshmana Rao, P.V., 2011. Alteration of blood brain barrier permeability by T-2 toxin: role of MMP-9 and inflammatory cytokines. Toxicology 280, 44-52.
38. Ries, C., Popp, T., Egea, V., Kehe, K., Jochum, M., 2009. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: up regulation in response to sulphur mustard. Toxicology 263, 26-31.
39. Roosterman, D., Goerge, T., Schneider, S.W., Bunnett, N.W., Steinhoff, M., 2006. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol. Rev. 86, 1309-1379.
40. Rosen, R.T., Rosen, J.D., 1982. Presence of four Fusarium mycotoxins and synthetic material in 'yellow rain'. Evidence for the use of chemical weapons in Laos. Biomed. Mass Spectrom. 9, 443-450.
41. Rosenstein, Y., Lafarge-Frayssinet, C., 1983. Inhibitory effect of Fusarium T2-toxin on lymphoid DNA and protein synthesis. Toxicol. Appl. Pharmacol. 70, 283-288.
42. Schiefer, H.B., Hancock, D.S., 1984. Systemic effects of topical application of T-2 toxin in mice. Toxicol. Appl. Pharmacol. 76, 464-472.
43. Shakarjian, M.P., Heck, D.E., Gray, J.P., Sinko, P.J., Gordon, M.K., Casillas, R.P., Heindel, N.D., Gerecke, D.R., Laskin, D.L., Laskin, J.D., 2010. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol. Sci. 114, 5-19.
44. Stark, A.A., 2005. Threat assessment of mycotoxins as weapons: molecular mechanisms of acute toxicity. J. Food Prot. 68, 1285-1293.
45. Sudakin, D.L., 2003. Trichothecenes in the environment: relevance to human health. Toxicol. Lett. 143, 97-107.
46. Sundstol Eriksen, G., Pettersson, H., Lundh, T., 2004. Comparative cytotoxicity of deoxynivalenol, nivalenol, their acetylated derivatives and de-epoxy metabolites. Food Chem. Toxicol. 42, 619-624.
47. Tellman, G., Olivier, G., 2006. Light cycler 480 real Time PCR System: innovative solutions for relative quantification. Biochemica 4, 16-18.
48. Wang, S., Zhang, J., Zhang, Y., Kern, S., Danner, R.L., 2008. Nitric oxide-p38 MAPK signaling stabilizes mRNA through AU-rich element-dependent and independent mechanisms. J. Leuko. Biol. 83, 982-990.
49. Wannemacher, R.W., Bunner, D.L., Neufeld, H.A., 1991. Toxicity of trichothecenes and other related mycotoxins in laboratory animals. In: Smith, J.E., Henderson, R.S. (Eds.), Mycotoxins and Animal Foods. CRC Press, Boca Raton, FL, pp. 499-552.
50. Warner, R.L., Brooks, K., Pestka, J.J., 1994. In vitro effects of vomitoxin (deoxynivalenol) on T-cell interleukin production and IgA secretion. Food Chem. Toxicol. 32, 617-625.
51. Watson, S.A., Mirocha, C.J., Hayes, A.W., 1984. Analysis for trichothecenes in samples from Southeast Asia associated with "Yellow Rain". Fundam. Appl. Toxicol. 4, 700-717.
52. WHO, 1990. Selected mycotoxins: ochratoxins, trichothecenes, ergot. In: Environmental Health Criteria 105. WHO, Geneva.
53. Yan, C., Boyd, D.D., 2007. Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 211, 19-26.